NEA Management Company, LLC
Filing Date
Global Rank
#1,290
/ 8,603
▼ 53
· as of Mar 2026
Top Industry
Biotechnology
94.6%
3Y Alpha vs SPY
+16.8%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+164.8%
SPY
+76.5%
Annualised alpha
+17.5%
Max drawdown
−36.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
25 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
20.0%
+1.9 pts
Top 5
62.6%
+2.3 pts
Top 10
88.2%
+1.1 pts
HHI
1,048
Diversified+57
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 95.7% | $1,671,003,389 |
| Consumer Defensive | 4.3% | $74,890,415 |
Last Quarter's Activity
Export CSVNew Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | 7,392,301 | $191,534,518 | |
| No positions match the current search. | ||||
25 positions ·
$1,745,893,804 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ACLX |
Arcellx, Inc.
Healthcare
|
Held | 3,045,262 | $349,656,982 | 20.03% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 2,285,561 | $260,873,932 | 14.94% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
NEW | 7,392,301 | $191,534,518 | 10.97% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 13,222,228 | $157,741,180 | 9.03% | |
| SVRA |
Savara Inc
Healthcare
|
Held | 24,471,264 | $133,613,101 | 7.65% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Held | 7,692,298 | $126,538,302 | 7.25% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 3,614,486 | $107,892,407 | 6.18% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Added | 4,023,219 | $78,653,931 | 4.51% | |
| COUR |
Coursera, Inc.
Consumer Defensive
|
Held | 12,867,769 | $74,890,415 | 4.29% | |
| AUPH |
Aurinia Pharmaceuticals Inc.
Healthcare
|
Held | 3,969,834 | $58,832,939 | 3.37% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Held | 4,118,621 | $52,182,928 | 2.99% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Held | 1,058,570 | $50,356,174 | 2.88% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Held | 1,960,169 | $21,777,477 | 1.25% | |
| CVRX |
CVRx, Inc.
Healthcare
|
Held | 2,026,083 | $19,166,745 | 1.10% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
Added | 1,297,893 | $14,692,148 | 0.84% | |
| CSBR |
Champions Oncology, Inc.
Healthcare
|
Held | 1,713,720 | $9,853,890 | 0.56% | |
| BDTX |
Black Diamond Therapeutics, Inc.
Healthcare
|
Held | 4,448,757 | $9,475,852 | 0.54% | |
| IVA |
Inventiva S.A.
Healthcare
|
Held | 1,462,586 | $8,117,352 | 0.46% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Held | 3,568,781 | $7,530,127 | 0.43% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Held | 464,398 | $4,774,011 | 0.27% | |
| SNTI |
Senti Biosciences Holdings, Inc.
Healthcare
|
Held | 3,775,615 | $3,065,799 | 0.18% | |
| MRKR |
Marker Therapeutics, Inc.
Healthcare
|
Held | 1,625,678 | $2,113,381 | 0.12% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
Held | 478,548 | $1,981,188 | 0.11% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Reduced | 1,000,000 | $329,000 | 0.02% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
Held | 50,005 | $250,025 | 0.01% |